Ole Wichmann

Best Publications

• Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion.

  Unknown

  695
  Citations

• Neurological complications of dengue virus infection.

  Francisco Javier Carod-Artal;Francisco Javier Carod-Artal;Ole Wichmann;Jeremy Farrar;Jeremy Farrar;Joaquim Gascón

  592
  Citations

• Phylogenetic and case-control study on hepatitis E virus infection in Germany.

  Ole Wichmann;Sven Schimanski;Judith Koch;Martin Kohler

  355
  Citations

• Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand

  Ole Wichmann;Suchat Hongsiriwon;Chureeratana Bowonwatanuwong;Kesinee Chotivanich

  350
  Citations

• Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis

  Gerhard Falkenhorst;Cornelius Remschmidt;Thomas Harder;Eva Hummers-Pradier

  259
  Citations

• Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators

  Ole Wichmann;Ole Wichmann;Joaquim Gascon;Mirjam Schunk;Sabino Puente

  252
  Citations

• Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review.

  H. C. Lewis;Ole Wichmann;Erwin Duizer

  251
  Citations

• Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review

  Unknown

  217
  Citations

• Cytomegalovirus (CMV) seroprevalence in the adult population of Germany.

  Raskit Lachmann;Anna Loenenbach;Anna Loenenbach;Tim Waterboer;Nicole Brenner

  182
  Citations

• Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.

  Unknown

  172
  Citations

• Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011.

  Yanina Balabanova;Andreas Gilsdorf;Silke Buda;Reinhard Burger

  172
  Citations

• Herpes zoster in Germany: Quantifying the burden of disease

  Unknown

  143
  Citations

• Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021.

  Thomas Harder;Wiebe Külper-Schiek;Sarah Reda;Marina Treskova-Schwarzbach

  138
  Citations

• Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study

  Birte Bödeker;Cornelius Remschmidt;Patrick Schmich;Ole Wichmann

  134
  Citations

• Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

  Ole Wichmann;Petra Stöcker;Gabriele Poggensee;Doris Altmann

  133
  Citations

• Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis

  Unknown

  131
  Citations

• Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany.

  Birte Bödeker;Birte Bödeker;Dietmar Walter;Sabine Reiter;Ole Wichmann

  131
  Citations

• Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community

  Bernhard Ultsch;Oliver Damm;Phillippe Beutels;Joke Bilcke

  128
  Citations

• Risk perception and information-seeking behaviour during the 2009/10 influenza A(H1N1)pdm09 pandemic in Germany

  Dietmar Walter;Merle Böhmer;Merle Böhmer;Sabine Reiter;Gérard Krause

  127
  Citations

• Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021.

  Thomas Harder;Judith Koch;Sabine Vygen-Bonnet;Wiebe Külper-Schiek

  123
  Citations